Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects

Free Radical Biology and Medicine

Volumn 35, Issue 7, 2003, Pages 772-781

  Mori, Trevor A ^a,b   Woodman, Richard J ^a   Burke, Valerie ^a   Puddey, Ian B ^a   Croft, Kevin D ^a   Beilin, Lawrence J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Box X 2213 GPO   (Australia)

Author keywords

Diabetes; Docosahexaenoic acid; Eicosapentaenoic acid; Fish oils; Free radicals; Isoprostanes; Lipid peroxidation; n 3 Fatty acids; Oxidative stress

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN II ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOCOSAHEXAENOIC ACID; FATTY ACID DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; ISOPROSTANE DERIVATIVE; OLIVE OIL; ORAL ANTIDIABETIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE MARKER; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GAS CHROMATOGRAPHY; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; TREATMENT OUTCOME; URINALYSIS;

EID: 0142258704     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00407-6     Document Type: Article

References (57)

1. Kannel W.B., McGee D.L. Diabetes and cardiovascular risk factors the Framingham study . Circulation. 59:1979;8-13.
2. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339:1998;229-234.
3. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications a new perspective on an old paradigm . Diabetes. 48:1999;1-9.
4. Lyons T.J. Oxidized low density lipoproteins a role in the pathogenesis of atherosclerosis in diabetes? Diabetic Med. 8:1991;411-419.
5. Giugliano D., Ceriello A., Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 19:1996;257-267.
6. Lipinski B. Pathophysiology of oxidative stress in diabetes mellitus. J. Diabetes Complicat. 15:2001;203-210.
7. Bierman E.L. Atherogenesis in diabetes. Arterioscler. Thromb. 12:1992;647-656.
8. Bellomo G., Maggi E., Poli M., Agosta F.G., Bollati P., Finardi G. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM. Diabetes. 44:1995;60-66.
9. Dandona P., Thusu K., Cook S., Snyder B., Makowski J., Armstrong D., Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet. 347:1996;444-445.
10. Morrow J.D., Roberts L.J. The isoprostanes unique bioactive products of lipid peroxidation . Prog. Lipid Res. 36:1997;1-21.
11. Morrow J.D. The isoprostanes their quantification as an index of oxidant stress status in vivo . Drug Metab. Rev. 32:2000;377-385.
12. 2-isoprostanes sensitive and specific non-invasive indices of lipid peroxidation in vivo . Atherosclerosis. 147:1999;1-10.
13. Mori T.A., Beilin L.J. ω3 Fatty acids, blood lipids and cardiovascular risk reduction. Curr. Opin. Lipidol. 12:2001;11-17.
14. Health effects of ω3 polyunsaturated fatty acids in seafoods. In: Simopoulos, A. P.; Kifer, R. R.; Martin, R. E.; Barlow, S. M., eds. World review of nutrition and dietetics, vol. 66. Basel: Karger; 1991.
15. Connor S.L., Connor W.E. Are fish oils beneficial in the prevention and treatment of coronary artery disease? Am. J. Clin. Nutr. 66:(Suppl.):1997;1020S- 1031S.
16. Friedberg C.E., Janssen M.J., Heine R.J., Grobbee D.E. Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care. 21:1998;494-500.
17. Montori V.M., Farmer A., Wollan P.C., Dinneen S.F. Fish oil supplementation in type 2 diabetes a quantitative systematic review . Diabetes Care. 23:2000;1407-1415.
18. Nenseter M.S., Drevon C.A. Dietary polyunsaturates and peroxidation of low density lipoprotein. Curr. Opin. Lipidol. 7:1996;8-13.
19. 2-isoprostane excretion in non-insulin dependent diabetic patients. Metabolism. 48:1999;1402-1408.
20. 2-isoprostane excretion . Redox Rep. 5:2000;45-46.
21. Mori T.A., Bao D.Q., Burke V., Puddey I.B., Beilin L.J. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension. 34:1999;253-260.
22. Woodman R.J., Mori T.A., Burke V., Puddey I.B., Watts G.F., Beilin L.J. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on glycaemic control, blood pressure and serum lipids in treated-hypertensive Type 2 diabetic patients. Am. J. Clin. Nutr. 76:2002;1007-1015.
23. Dunstan D.W., Mori T.A., Puddey I.B., Beilin L.J., Burke V., Morton A.R., Stanton K.G. The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomized controlled study. Diabetes Care. 20:1997;913-921.
24. Mori T.A., Burke V., Puddey I.B., Watts G.F., O'Neal D.N., Best J.D., Beilin L.J. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am. J. Clin. Nutr. 71:2000;1085-1094.
25. Rifai N., Tracy R.P., Ridker P.M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin. Chem. 45:1999;2136-2141.
26. 2-isoprostanes using gas chromatography-mass spectrometry. Analyt. Biochem. 268:1999;117-125.
27. Lewis J., Holt R. NUTTAB 91-92 Nutrient tables for use in Australia. Nutrient tables for use in Australia. 1991;National Food Authority, Australian Government Publishing Service, Canberra.
28. 2α isoprostane levels are lowered in pigs fed an (n-3) polyunsaturated fatty acid supplemented diet following occlusion of the left anterior descending coronary artery. Nutr. Res. 20:2000;675-684.
29. 2-isoprostanes. Am. J. Clin. Nutr. 72:2000;714-722.
30. Mohanty P., Hamouda W., Garg R., Aljada A., Ghanim H., Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J. Clin. Endocrinol. Metab. 85:2000;2970-2973.
31. Dandona P., Mohanty P., Ghanim H., Aljada A., Browne R., Hamouda W., Prabhala A., Afzal A., Garg R. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J. Clin. Endocrinol. Metab. 86:2001;355-362.
32. Davi G., Guagnano M.T., Ciabattoni G., Basili S., Falco A., Marinopiccoli M., Nutini M., Sensi S., Patrono C. Platelet activation in obese women role of inflammation and oxidant stress . JAMA. 288:2002;2008-2014.
33. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation. 105:2002;1135-1143.
34. Schmidt M.I., Duncan B.B., Sharrett A.R., Lindberg G., Savage P.J., Offenbacher S., Azambuja M.I., Tracy R.P., Heiss G. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study) a cohort study . Lancet. 353:1999;1649-1652.
35. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 286:2001;327-334.
36. Nilsson J., Jovinge S., Niemann A., Reneland R., Lithell H. Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 18:1998;1199-1202.
37. Babior B.M. Phagocytes and oxidative stress. Am. J. Med. 109:2000;33-44.
38. 2α and platelet activation in diabetes mellitus - effects of improved metabolic control and vitamin E supplementation. Circulation. 99:1999;224-229.
39. 2-isoprostanes as measures of oxidative stress in type 2 diabetes. Clin. Chem. 47:2001;1974-1979.
40. 2α levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 368:1995;225-229.
41. Mori T.A., Watts G.F., Burke V., Bao D.Q., Hilme E., Beilin L.J., Puddey I.B. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on forearm vascular reactivity of the microcirculation in hyperlipidaemic, overweight men. Circulation. 102:2000;1264-1269.
42. Liu J., Yeo H.C., Doniger S.J., Ames B.N. Assay of aldehydes from lipid peroxidation gas chromatography-mass spectrometry compared to thiobarbituric acid . Anal. Biochem. 245:1997;161-166.
43. Brude I.R., Drevon C.A., Hjermann I., Seljeflot I., Lund-Katz S., Saarem K., Sandstad B., Solvoll K., Halvorsen B., Arnesen H., Nenseter M.S. Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants. Arterioscler. Thromb. Vasc. Biol. 17:1997;2576-2588.
44. Calder P.C. N-3 polyunsaturated fatty acids, inflammation and immunity pouring oil on troubled waters or another fishy tale? Nutr. Res. 21:2001;309-341.
45. Hiramatsu K., Arimori S. Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes. 37:1988;832-837.
46. Thompson P.J., Misso N.L., Passarelli M., Phillips M.J. The effect of eicosapentaenoic acid consumption on human neutrophil chemiluminescence. Lipids. 26:1991;1223-1226.
47. Varming K., Schmidt E.B., Svaneborg N., Moller J.M., Lervang H.H., Grunnet N., Jersild C., Dyerberg J. The effect of n-3 fatty acids on neutrophil chemiluminescence. Scand. J. Clin. Lab. Invest. 55:1995;47-52.
48. Fisher M., Levine P.H., Weiner B.H., Johnson M.H., Doyle E.M., Ellis P.A., Hoogasian J.J. Dietary n-3 fatty acid supplementation reduces superoxide production and chemiluminescence in a monocyte-enriched preparation of leukocytes. Am. J. Clin. Nutr. 51:1990;804-808.
49. Fisher M., Upchurch K.S., Levine P.H., Johnson M.H., Vaudreuil C.H., Natale A., Hoogasian J.J. Effects of dietary fish oil supplementation on polymorphonuclear leukocyte inflammatory potential. Inflammation. 10:1986;387-392.
50. Sirtori C.R., Gatti E., Tremoli E., Galli C., Gianfranceschi G., Franceschini G., Colli S., Maderna P., Marangoni F., Perego P., Stragliotto E. Olive oil, corn oil, and n-3 fatty acids differently affect lipids, lipoproteins, platelets, and superoxide formation in Type 2 hypercholesterolemia. Am. J. Clin. Nutr. 56:1992;113-122.
51. Carbonell T., Rodenas J., Miret S., Mitjavila M.T. Fish oil and oxidative stress by inflammatory leukocytes. Free Radic. Res. 27:1997;591-597.
52. De Caterina R., Zampolli A. n-3 fatty acids antiatherosclerotic effects . Lipids. 36:(Suppl.):2001;S69-S78.
53. Applegate K.R., Glomset J.A. Computer-based modeling of the conformation and packing properties of docosahexaenoic acid. J. Lipid Res. 27:1986;658-680.
54. von Schacky C., Siess W., Fischer S., Weber P.C. A comparative study of eicosapentaenoic acid metabolism by human platelets in vivo and in vitro. J. Lipid Res. 26:1985;457-464.
55. Demoz A., Willumsen N., Berge R.K. Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic antioxidant defense in mice. Lipids. 27:1992;968-971.
56. Olivieri O., Negri M., De Gironcoli M., Bassi A., Guarini P., Stanzial A.M., Grigolini L., Ferrari S., Corrocher R. Effects of dietary fish oil on malondialdehyde production and glutathione peroxidase activity in hyperlipidaemic patients. Scand. J. Clin. Lab. Invest. 48:1988;659-665.
57. Takahashi M., Tsuboyama-Kasaoka N., Nakatani T., Ishii M., Tsutsumi S., Aburatani H., Ezaki O. Fish oil feeding alters liver gene expressions to defend against PPAR alpha activation and ROS production. Am. J. Physiol. Gastrointest. Liver Physiol. 282:2002;G338-G348.